Product Code: ETC6853207 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Croatia Incretin-Based Drugs Market Overview |
3.1 Croatia Country Macro Economic Indicators |
3.2 Croatia Incretin-Based Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Croatia Incretin-Based Drugs Market - Industry Life Cycle |
3.4 Croatia Incretin-Based Drugs Market - Porter's Five Forces |
3.5 Croatia Incretin-Based Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Croatia Incretin-Based Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Croatia Incretin-Based Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Croatia Incretin-Based Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Croatia |
4.2.2 Growing awareness about the benefits of incretin-based drugs |
4.2.3 Rising investments in healthcare infrastructure in Croatia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from alternative diabetes treatment options |
4.3.3 Limited reimbursement policies for incretin-based drugs |
5 Croatia Incretin-Based Drugs Market Trends |
6 Croatia Incretin-Based Drugs Market, By Types |
6.1 Croatia Incretin-Based Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Croatia Incretin-Based Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Croatia Incretin-Based Drugs Market Revenues & Volume, By GLP-1 receptor agonists, 2021- 2031F |
6.1.4 Croatia Incretin-Based Drugs Market Revenues & Volume, By DPP-4 inhibitors, 2021- 2031F |
6.2 Croatia Incretin-Based Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Croatia Incretin-Based Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Croatia Incretin-Based Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Croatia Incretin-Based Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Croatia Incretin-Based Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Croatia Incretin-Based Drugs Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 Croatia Incretin-Based Drugs Market Revenues & Volume, By Online Providers, 2021- 2031F |
7 Croatia Incretin-Based Drugs Market Import-Export Trade Statistics |
7.1 Croatia Incretin-Based Drugs Market Export to Major Countries |
7.2 Croatia Incretin-Based Drugs Market Imports from Major Countries |
8 Croatia Incretin-Based Drugs Market Key Performance Indicators |
8.1 Number of new diabetes cases diagnosed annually in Croatia |
8.2 Percentage of healthcare professionals prescribing incretin-based drugs |
8.3 Investment in diabetes research and development in Croatia |
9 Croatia Incretin-Based Drugs Market - Opportunity Assessment |
9.1 Croatia Incretin-Based Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Croatia Incretin-Based Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Croatia Incretin-Based Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Croatia Incretin-Based Drugs Market - Competitive Landscape |
10.1 Croatia Incretin-Based Drugs Market Revenue Share, By Companies, 2024 |
10.2 Croatia Incretin-Based Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |